MB1 Common Cancers (2)

to view the slide as a whole, click here

  Age Sex Organ Diagnosis pTNM Stage    
1
66
F breast infiltrating duct carcinoma T2N0M0
IIA
view at 20X view at 40X
2
43
F breast infiltrating duct carcinoma T3N1M0
IIIA
view at 20X view at 40X
3
58
F breast infiltrating duct carcinoma T2N1M0
IIIA
view at 20X view at 40X
4
46
F breast infiltrating duct carcinoma T3N1M0
IIIB
view at 20X view at 40X
5
71
F breast infiltrating papillary carcinoma with signet ring cell T3N1M0
IIIA
view at 20X view at 40X
6
37
F breast infiltrating duct carcinoma T3N1M0
IIIA
view at 20X view at 40X
7
59
F breast mixed infiltrating duct and lobular carcinoma T3N1M0
IIIA
view at 20X view at 40X
8
30
F breast medullary carcinoma T3N0M0
IIB
view at 20X view at 40X
9
47
F breast atypical medullary carcinoma T2N1M0
IIB
view at 20X view at 40X
10
46
F breast infiltrating duct carcinoma T3N1M0
IIIA
view at 20X view at 40X
11
32
M liver combined hepatocellular and cholangiocarcinoma T3N0M0
IIIA
view at 20X view at 40X
12
57
M liver hepatocellular carcinoma T3N0M0
IIIA
view at 20X view at 40X
13
58
F liver hepatocellular carcinoma T2N0M0
II
view at 20X view at 40X
14
20
M liver hepatocellular carcinoma T4N0M0
IVA
view at 20X view at 40X
15
63
F liver hepatocellular carcinoma T2N0M0
II
view at 20X view at 40X
16
66
F liver hepatocellular carcinoma T2N0M0
II
view at 20X view at 40X
17
61
M liver hepatocellular carcinoma T3N0M0
IIIA
view at 20X view at 40X
18
52
M liver hepatocellular carcinoma T3N0M0
IIIA
view at 20X view at 40X
19
50
M liver combined hepatocellular and cholangiocarcinoma T3N1M0
IIIB
view at 20X view at 40X
20
56
M liver hepatocellular carcinoma T3N0M0
IIIA
view at 20X view at 40X
21
53
M urinary mucinous adenocarcinoma  
view at 20X view at 40X
22
60
M urinary transitional cell carcinoma T3bN1M0
IV
view at 20X view at 40X
23
72
M urinary transitional cell carcinoma T3bN1M0
IV
view at 20X view at 40X
24
65
M urinary transitional cell carcinoma T4aN1M1
IV
view at 20X view at 40X
25
74
M urinary papillary transitional cell carcinoma T1N0M0
I
view at 20X view at 40X
26
63
F urinary papillary transitional cell carcinoma T1N0M0
I
view at 20X view at 40X
27
58
M urinary transitional cell carcinoma T3NxM0
III
view at 20X view at 40X
28
46
M urinary papillary transitional cell carcinoma T1N0M0
I
view at 20X view at 40X
29
76
M urinary transitional cell carcinoma T3NxM0
III
view at 20X view at 40X
30
63
M urinary transitional cell carcinoma T3bN0M0
III
view at 20X view at 40X
31
57
F ovary papillary serous cystadeno-ca T3bN1M0
IIIc
view at 20X view at 40X
32
48
F ovary papillary serous cystadeno-ca, moderately T3cN0M0
IIIc
view at 20X view at 40X
33
60
F ovary

papillary serous cystadeno-ca, poorly differentitated

T2cN0M0
IIc
view at 20X view at 40X
34
41
F ovary papillary serous cystadeno-ca, moderately T2cN1M0
IIIc
view at 20X view at 40X
35
64
F ovary papillary serous cystadeno-ca T3cN0M0
IIIc
view at 20X view at 40X
36
60
F ovary papillary serous cystadeno-ca T3cN1M0
IIIc
view at 20X view at 40X
37
54
F ovary papillary serous cystadeno-ca T3aN0M0
IIIa
view at 20X view at 40X
38
58
F ovary papillary serous cystadeno-ca T2cN0M0
IIc
view at 20X view at 40X
39
16
F ovary mucinous cystadeno-ca T1aN0M0
Ia
view at 20X view at 40X
40
57
F ovary serous cystadeno-ca, poorly differentiated T3cN0M0
IIIc
view at 20X view at 40X
41
66
M pancreas ductal ad-ca, moderately differentiated T4N1aM0
IVA
view at 20X view at 40X
42
63
M pancreas ductal ad-ca, moderately differentiated T3N0M0
II
view at 20X view at 40X
43
62
M pancreas ductal ad-ca, moderately differentiated T2N1bM0
III
view at 20X view at 40X
44
45
M pancreas ductal ad-ca, moderately differentiated T4N1aM0
IVA
view at 20X view at 40X
45
64
F pancreas ductal ad-ca, moderately differentiated T4N0M0
IVA
view at 20X view at 40X
46
64
F pancreas ductal ad-ca, moderately differentiated T2N1bM0
III
view at 20X view at 40X
47
63
M pancreas ductal ad-ca, poorly differentiated T4NxM0
IVA
view at 20X view at 40X
48
46
M pancreas ductal ad-ca, moderately differentiated T3N1bM0
III
view at 20X view at 40X
49
54
M pancreas ductal ad-ca, moderately differentiated T3N1bM0
III
view at 20X view at 40X
50
40
M pancreas ductal ad-ca, moderately differentiated T3N1bM0
III
view at 20X view at 40X
51
85
M prostate adenocarcinoma TxNxM1
IV
view at 20X view at 40X
52
79
M prostate adenocarcinoma T2aNxM1
IV
view at 20X view at 40X
53
53
M prostate adenocarcinoma T2aNxM1
IV
view at 20X view at 40X
54
72
M prostate adenocarcinoma

TxNxM1 (D2)

IV
view at 20X view at 40X
55
82
M prostate adenocarcinoma T2N0M1
IV
view at 20X view at 40X
56
76
M prostate adenocarcinoma T3aN0M0
III
view at 20X view at 40X
57
56
M prostate adenocarcinoma T2N1M0
IV
view at 20X view at 40X
58
66
M prostate adenocarcinoma T4N0M0
IV
view at 20X view at 40X
59
54
M prostate adenocarcinoma T1aN0M0 (G2)
I
view at 20X view at 40X
60
    carbon  
view at 20X view at 40X